The global market for Therapeutic Plasma Exchange (TPE) Systems was valued at US$ 490 million in the year 2024 and is projected to reach a revised size of US$ 718 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Therapeutic Plasma Exchange (TPE) systems are specialized medical devices used for a treatment called plasma exchange, which involves removing and replacing a patient's plasma to treat various diseases, especially those involving the immune system, blood disorders, or toxin accumulation. TPE is a more comprehensive version of plasmapheresis, as it involves not only separating plasma but also replacing it with a substitute fluid to maintain the proper blood volume and prevent complications like hypotension (low blood pressure).
North American market for Therapeutic Plasma Exchange (TPE) Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Therapeutic Plasma Exchange (TPE) Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Therapeutic Plasma Exchange (TPE) Systems include Terumo BCT, Fresenius Kabi, Haemonetics, Baxter, B. Braun, Nikkiso, Miltenyi Biotec, Asahi Kasei Medical, NxStage Medical (Fresenius Medical Care), Kaneka Medix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Therapeutic Plasma Exchange (TPE) Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Plasma Exchange (TPE) Systems.
The Therapeutic Plasma Exchange (TPE) Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Plasma Exchange (TPE) Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Plasma Exchange (TPE) Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Terumo BCT
Fresenius Kabi
Haemonetics
Baxter
B. Braun
Nikkiso
Miltenyi Biotec
Asahi Kasei Medical
NxStage Medical (Fresenius Medical Care)
Kaneka Medix
Nigale
Haier Biomedical
Scinomed
Medica SPA
Dahua Medical Instrument
Chengdu Jiaying Medical Products
Segment by Type
Centrifugal Separation
Membrane Separation
Segment by Application
Hospitals
Blood Centers
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Plasma Exchange (TPE) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Plasma Exchange (TPE) Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Overview
1.1 Product Definition
1.2 Therapeutic Plasma Exchange (TPE) Systems by Type
1.2.1 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Centrifugal Separation
1.2.3 Membrane Separation
1.3 Therapeutic Plasma Exchange (TPE) Systems by Application
1.3.1 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Blood Centers
1.3.4 Others
1.4 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Therapeutic Plasma Exchange (TPE) Systems Revenue 2020-2031
1.4.2 Global Therapeutic Plasma Exchange (TPE) Systems Sales 2020-2031
1.4.3 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Competition by Manufacturers
2.1 Global Therapeutic Plasma Exchange (TPE) Systems Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Therapeutic Plasma Exchange (TPE) Systems Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Therapeutic Plasma Exchange (TPE) Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Therapeutic Plasma Exchange (TPE) Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Plasma Exchange (TPE) Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Plasma Exchange (TPE) Systems, Product Type & Application
2.7 Global Key Manufacturers of Therapeutic Plasma Exchange (TPE) Systems, Date of Enter into This Industry
2.8 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Competitive Situation and Trends
2.8.1 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Therapeutic Plasma Exchange (TPE) Systems Players 麻豆原创 Share by Revenue
2.8.3 Global Therapeutic Plasma Exchange (TPE) Systems Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Scenario by Region
3.1 Global Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Region: 2020-2031
3.2.1 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Region: 2020-2025
3.2.2 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Region: 2026-2031
3.3 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Region: 2020-2031
3.3.1 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Region: 2020-2025
3.3.2 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Region: 2026-2031
3.4 North America Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Facts & Figures by Country
3.4.1 North America Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Therapeutic Plasma Exchange (TPE) Systems Sales by Country (2020-2031)
3.4.3 North America Therapeutic Plasma Exchange (TPE) Systems Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Facts & Figures by Country
3.5.1 Europe Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Therapeutic Plasma Exchange (TPE) Systems Sales by Country (2020-2031)
3.5.3 Europe Therapeutic Plasma Exchange (TPE) Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Therapeutic Plasma Exchange (TPE) Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Therapeutic Plasma Exchange (TPE) Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Therapeutic Plasma Exchange (TPE) Systems Sales by Country (2020-2031)
3.7.3 Latin America Therapeutic Plasma Exchange (TPE) Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Therapeutic Plasma Exchange (TPE) Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Therapeutic Plasma Exchange (TPE) Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Type (2020-2031)
4.1.1 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Type (2020-2025)
4.1.2 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Type (2026-2031)
4.1.3 Global Therapeutic Plasma Exchange (TPE) Systems Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Type (2020-2031)
4.2.1 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Type (2020-2025)
4.2.2 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Type (2026-2031)
4.2.3 Global Therapeutic Plasma Exchange (TPE) Systems Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Therapeutic Plasma Exchange (TPE) Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Application (2020-2031)
5.1.1 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Application (2020-2025)
5.1.2 Global Therapeutic Plasma Exchange (TPE) Systems Sales by Application (2026-2031)
5.1.3 Global Therapeutic Plasma Exchange (TPE) Systems Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Application (2020-2031)
5.2.1 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Application (2020-2025)
5.2.2 Global Therapeutic Plasma Exchange (TPE) Systems Revenue by Application (2026-2031)
5.2.3 Global Therapeutic Plasma Exchange (TPE) Systems Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Therapeutic Plasma Exchange (TPE) Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Terumo BCT
6.1.1 Terumo BCT Company Information
6.1.2 Terumo BCT Description and Business Overview
6.1.3 Terumo BCT Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Terumo BCT Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.1.5 Terumo BCT Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius Kabi Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Haemonetics
6.3.1 Haemonetics Company Information
6.3.2 Haemonetics Description and Business Overview
6.3.3 Haemonetics Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Haemonetics Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.3.5 Haemonetics Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Company Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B. Braun Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Nikkiso
6.6.1 Nikkiso Company Information
6.6.2 Nikkiso Description and Business Overview
6.6.3 Nikkiso Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nikkiso Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.6.5 Nikkiso Recent Developments/Updates
6.7 Miltenyi Biotec
6.7.1 Miltenyi Biotec Company Information
6.7.2 Miltenyi Biotec Description and Business Overview
6.7.3 Miltenyi Biotec Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Miltenyi Biotec Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.7.5 Miltenyi Biotec Recent Developments/Updates
6.8 Asahi Kasei Medical
6.8.1 Asahi Kasei Medical Company Information
6.8.2 Asahi Kasei Medical Description and Business Overview
6.8.3 Asahi Kasei Medical Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Asahi Kasei Medical Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.8.5 Asahi Kasei Medical Recent Developments/Updates
6.9 NxStage Medical (Fresenius Medical Care)
6.9.1 NxStage Medical (Fresenius Medical Care) Company Information
6.9.2 NxStage Medical (Fresenius Medical Care) Description and Business Overview
6.9.3 NxStage Medical (Fresenius Medical Care) Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NxStage Medical (Fresenius Medical Care) Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.9.5 NxStage Medical (Fresenius Medical Care) Recent Developments/Updates
6.10 Kaneka Medix
6.10.1 Kaneka Medix Company Information
6.10.2 Kaneka Medix Description and Business Overview
6.10.3 Kaneka Medix Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kaneka Medix Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.10.5 Kaneka Medix Recent Developments/Updates
6.11 Nigale
6.11.1 Nigale Company Information
6.11.2 Nigale Description and Business Overview
6.11.3 Nigale Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nigale Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.11.5 Nigale Recent Developments/Updates
6.12 Haier Biomedical
6.12.1 Haier Biomedical Company Information
6.12.2 Haier Biomedical Description and Business Overview
6.12.3 Haier Biomedical Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Haier Biomedical Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.12.5 Haier Biomedical Recent Developments/Updates
6.13 Scinomed
6.13.1 Scinomed Company Information
6.13.2 Scinomed Description and Business Overview
6.13.3 Scinomed Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Scinomed Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.13.5 Scinomed Recent Developments/Updates
6.14 Medica SPA
6.14.1 Medica SPA Company Information
6.14.2 Medica SPA Description and Business Overview
6.14.3 Medica SPA Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Medica SPA Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.14.5 Medica SPA Recent Developments/Updates
6.15 Dahua Medical Instrument
6.15.1 Dahua Medical Instrument Company Information
6.15.2 Dahua Medical Instrument Description and Business Overview
6.15.3 Dahua Medical Instrument Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Dahua Medical Instrument Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.15.5 Dahua Medical Instrument Recent Developments/Updates
6.16 Chengdu Jiaying Medical Products
6.16.1 Chengdu Jiaying Medical Products Company Information
6.16.2 Chengdu Jiaying Medical Products Description and Business Overview
6.16.3 Chengdu Jiaying Medical Products Therapeutic Plasma Exchange (TPE) Systems Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Chengdu Jiaying Medical Products Therapeutic Plasma Exchange (TPE) Systems Product Portfolio
6.16.5 Chengdu Jiaying Medical Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Plasma Exchange (TPE) Systems Industry Chain Analysis
7.2 Therapeutic Plasma Exchange (TPE) Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Plasma Exchange (TPE) Systems Production Mode & Process Analysis
7.4 Therapeutic Plasma Exchange (TPE) Systems Sales and 麻豆原创ing
7.4.1 Therapeutic Plasma Exchange (TPE) Systems Sales Channels
7.4.2 Therapeutic Plasma Exchange (TPE) Systems Distributors
7.5 Therapeutic Plasma Exchange (TPE) Systems Customer Analysis
8 Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Dynamics
8.1 Therapeutic Plasma Exchange (TPE) Systems Industry Trends
8.2 Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Drivers
8.3 Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Challenges
8.4 Therapeutic Plasma Exchange (TPE) Systems 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Terumo BCT
Fresenius Kabi
Haemonetics
Baxter
B. Braun
Nikkiso
Miltenyi Biotec
Asahi Kasei Medical
NxStage Medical (Fresenius Medical Care)
Kaneka Medix
Nigale
Haier Biomedical
Scinomed
Medica SPA
Dahua Medical Instrument
Chengdu Jiaying Medical Products
听
听
*If Applicable.
